Our research showed that Sema7a and its receptor integrin-β1 were overexpressed in lung tissue in OVA-treated mice (Figures 2A–F; P < 0.01); treatment with anti-Sema7a was effective in alleviating AR in the model of chronic asthma. Here, SEMA7A is linked to chronic asthma.